Genmab Has First Wholly Owned Antibodies In Phase III, Hunts For More

Shifting From Out-Licensing To Retaining Assets

 
• By Mandy Jackson
  
Genmab bought ProfoundBio last year and hopes to sign another deal this year (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Scrip